Jinhai Fan
Overview
Explore the profile of Jinhai Fan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
81
Citations
923
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li J, Jiang Y, Ma M, Wang L, Jing M, Yang Z, et al.
J Transl Med
. 2025 Jan;
23(1):135.
PMID: 39885578
Background: The progression of bladder cancer (BC) from non-muscle-invasive bladder cancer (NMIBC) to muscle-invasive bladder cancer (MIBC) significantly increases disease severity. Although the tumor microenvironment (TME) plays a pivotal role...
2.
Li J, Jiang Y, Ma M, Wang L, Jing M, Yang Z, et al.
Cancer Med
. 2024 Dec;
13(24):e70506.
PMID: 39711402
Background: Immunotherapy has shown promise for bladder cancer (BC) treatment but is effective only in a subset of patients. Understanding the tumor microenvironment (TME) and its regulators, such as the...
3.
Zhang Y, Fan J
Diabetol Metab Syndr
. 2024 Nov;
16(1):279.
PMID: 39578862
Background: The prevalence of metabolic syndrome is on the rise globally. Understanding the etiology and discovering potential treatment target have become a priority. Observational data have linked gut microbiota with...
4.
Jian Y, Zhang N, Bi Y, Liu X, Fan J, Wu W, et al.
ACS Sens
. 2024 Nov;
10(1):213-224.
PMID: 39535999
Utilizing electronic noses (e-noses) with pattern recognition algorithms offers a promising noninvasive method for the early detection of urinary bladder cancer (UBC). However, limited clinical samples often hinder existing artificial...
5.
Ma M, Li X, Jing M, Zhang P, Zhang M, Wang L, et al.
Adv Sci (Weinh)
. 2024 Sep;
11(42):e2409081.
PMID: 39258781
Peptide-based drugs hold great potential for cancer treatment, and their effectiveness is driven by mechanisms on how peptides target cancer cells and escape from potential lysosomal entrapment post-endocytosis. Yet, the...
6.
Li K, Zhong W, Fan J, Wang S, Yu D, Xu T, et al.
Nat Cancer
. 2024 Sep;
5(10):1465-1478.
PMID: 39256488
Programmed death 1 blockade (tislelizumab) has been approved for metastatic urothelial carcinoma but not as part of neoadjuvant therapy for muscle-invasive bladder cancer (MIBC). In this multicenter single-arm trial (ChiCTR2000037670),...
7.
Yang T, Fan J, Pei X, Liang H, Fan J
Bladder Cancer
. 2024 Jul;
8(4):371-378.
PMID: 38994183
Background: T1 substaging is a predictive factor for non-muscle-invasive bladder cancer, and two types of T1 substaging systems (T1a/b/c and T1m/e) are currently in use. However, the predictive ability of...
8.
Song R, Wu K, Ma M, Wang L, Jiang Y, Li J, et al.
BMC Nephrol
. 2024 Jun;
25(1):190.
PMID: 38831279
Purpose: Some studies have found that the pathological formation of kidney stones is closely related to injury and inflammatory response. Behaviors such as dietary composition, physical activity, obesity and smoking...
9.
Pu Y, He L, Wang X, Zhang Y, Zhao S, Fan J
J Glob Health
. 2024 May;
14:04095.
PMID: 38818613
Background: Urticaria places a significant burden on individuals and society due to its widespread nature. The aim of this study was to evaluate the burden of urticaria in different regions...
10.
Prognosis and biological function of SGOL1 in clear cell renal cell carcinoma: a multiomics analysis
Yang Z, Jiang Y, Wang L, Yu B, Cai H, Fan J, et al.
BMC Med Genomics
. 2024 Feb;
17(1):60.
PMID: 38383432
Background: Shugoshin-1 (SGOL1) is a mammalian ortholog of Shugoshin in yeast and is essential for precise chromosome segregation during mitosis and meiosis. Aberrant SGOL1 expression was reported to be closely...